You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resected early stage Non-small Cell Lung Cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 10, 2023

Healthy, no Evidence of Disease, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Los Angeles (light-scattering

Terminated
  • Healthy, no Evidence of Disease
  • +4 more
  • light-scattering spectroscopy
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Nov 11, 2021

Squamous Cell Lung Cancer Trial in Bronx (Necitumumab-Gemcitabine-Cisplatin, Evaluation to determine if patient is a candidate

Terminated
Has Results
  • Squamous Cell Lung Cancer
  • Bronx, New York
    Montefiore Medical Center
Mar 3, 2020

The Significance of Circulating Microvesicles in Pulmonary

Not yet recruiting
  • Pulmonary Hypertension Due to Chronic
  • +3 more
  • Catheterization
  • Strasbourg, France
    Hôpitaux Universitaire de Strasbourg - Service Pneumologie - cen
Jun 21, 2022

Tumors, Arteriovenous Malformation of CNS, Trigeminal Neuralgia Trial in Australia, Turkey, United States (SRS/SBRT)

Recruiting
  • Neoplasms
  • +2 more
  • SRS/SBRT
  • Colorado Springs, Colorado
  • +24 more
Jul 19, 2021

Prostatic Tumors Trial in China (Apalutamide, Placebo, Androgen-deprivation Therapy (ADT))

Recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +29 more
Aug 15, 2022

A Prospective, Multi-center Study

Not yet recruiting
  • Hematuria
  • Urothelial Carcinoma
  • urine sample collection
  • Shanghai, Shanghai, China
    Changhai Hospital
May 29, 2023

Advanced and Metastatic Urothelial Cancer Trial in France, Spain, United States (futibatinib and pembrolizumab)

Recruiting
  • Advanced and Metastatic Urothelial Cancer
  • futibatinib and pembrolizumab
  • San Francisco, California
  • +17 more
Oct 25, 2022

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (donor lymphocytes)

Completed
Has Results
  • Leukemia
  • +3 more
  • donor lymphocytes
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 21, 2020

Advanced Primary Liver Cancer Trial (IBR900 combined with Lenvatinib, IBR900 combined with Bevacizumab)

Not yet recruiting
  • Advanced Primary Liver Cancer
  • IBR900 combined with Lenvatinib
  • IBR900 combined with Bevacizumab
  • (no location specified)
Jun 6, 2022

Cancer Metastatic to Liver, Cancer Colorectal Trial in Copenhagen (Exercise)

Not yet recruiting
  • Cancer Metastatic to Liver
  • Cancer Colorectal
  • Exercise
  • Copenhagen, Denmark
    Rigshospitalet (CFAS)
Oct 11, 2022

Endometrial Cancer Testing With Vaginal and Endometrial Cell

Completed
  • Endometrial Cancer
  • Gynecological Cancers
    • Rochester, Minnesota
      Mayo Clinic, Rochester
    Nov 16, 2020

    Multiple Myeloma Trial in Tampa (biological, procedure, drug)

    Active, not recruiting
    • Multiple Myeloma
    • Survivin Vaccine
    • +3 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 7, 2022

    Atherosclerosis, Endothelial Dysfunction, Peri-Implantitis Trial in Catania (Non-surgical periodontal treatment)

    Recruiting
    • Atherosclerosis
    • +3 more
    • Non-surgical periodontal treatment
    • Catania, Italy
      AOU Policlinico G. Rodolico
    Jun 7, 2023

    Sarcoma, Merkel Cell Carcinoma Trial in United States (CRD3874)

    Recruiting
    • Sarcoma
    • Merkel Cell Carcinoma
    • Basking Ridge, New Jersey
    • +6 more
    Aug 28, 2023

    Evaluation of OE-MRI in Patients With H&N Cancer

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Oxygen Enhanced MRI scan
    • Nottingham, Nottinghamshire, United Kingdom
      Queens Medical Centre
    Sep 30, 2022

    Renal Cell Carcinoma Trial (Pembrolizumab, Axitinib, Sunitinib)

    Active, not recruiting
    Has Results
    • Renal Cell Carcinoma
    • Pembrolizumab
    • +2 more
    • (no location specified)
    Aug 17, 2022

    BCLC Stage C Hepatocellular Carcinoma Trial in Hangzhou (TACE, Tilelizumab, Sorafenib)

    Not yet recruiting
    • BCLC Stage C Hepatocellular Carcinoma
    • TACE
    • +2 more
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Aug 10, 2021

    Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

    Active, not recruiting
    • Adult Acute Myeloid Leukemia in Remission
    • +12 more
    • Duarte, California
      City of Hope Medical Center
    Feb 17, 2022

    Stage III Colorectal Cancer, Circulating Tumor DNA Trial in Shanghai (ctDNA dynamic monitoring)

    Recruiting
    • Stage III Colorectal Cancer
    • Circulating Tumor DNA
    • ctDNA dynamic monitoring
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Dec 3, 2021

    Laughter, Menopause, Stress Trial in Famagusta (Laughter Yoga)

    Not yet recruiting
    • Laughter
    • +3 more
    • Laughter Yoga
    • Famagusta, Cyprus
      Dilek Karaoğlan Gülevi
    Jun 12, 2023

    Tumor, Breast Trial in Seoul (Scalp cooling system 2)

    Completed
    • Neoplasm, Breast
    • Scalp cooling system 2
    • Seoul, Korea, Republic of
      Samsung Medical Center, Ilwon-ro 81, Gangnam-gu
    Dec 14, 2022

    MDS Trial (Imetelstat)

    Available
    • Myelodysplastic Syndromes
    • (no location specified)
    Jun 30, 2023

    Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,

    Active, not recruiting
    • Hematopoietic Cell Transplantation Recipient
    • Plasma Cell Myeloma
    • Ixazomib Citrate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 8, 2022

    Infant, Extremely Premature, Acute Lung Injury, Chronic Lung Disease of Prematurity Trial in Tucson (Infants in the study group

    Recruiting
    • Infant, Extremely Premature
    • +3 more
    • Infants in the study group (S/B group) will receive surfactant 2.5 mls/kg and Budesonide 0.5 mg (1mL)
    • Infants in the control group (S/P group) receive placebo (Normal saline 1mL)
    • Tucson, Arizona
      University of Arizona
    Oct 31, 2022